Skip to main content
Livermore
Livermore
ZHEN

Captrust Financial Advisors

SEC CIK
0001512024
Latest filing
Aug 13, 2026

ADPT holding history

Adaptive Biotechnologies Corp in every 13F filed by Captrust Financial Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ADPT overviewAll 13F holders of ADPTFull Q2 2026 holdings

Shares (Q2 2026)
23,459
Value
$503.2K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of ADPT by Captrust Financial Advisors, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202623,459$503.2K<0.1%+2,559+12.2%AddedHolders
Q1 202620,900$290.0K<0.1%+665+3.3%AddedHolders
Q4 202520,235$328.6K<0.1%+305+1.5%AddedHolders
Q3 202519,930$298.2K<0.1%+4,168+26.4%AddedHolders
Q2 202515,762$183.6K<0.1%+1,119+7.6%AddedHolders
Q1 202514,643$108.8K<0.1%+1,059+7.8%AddedHolders
Q4 202413,584$81.4K<0.1%+654+5.1%AddedHolders
Q3 202412,930$66.2K<0.1%+1,617+14.3%AddedHolders
Q2 202411,313$41.0K<0.1%+1,019+9.9%AddedHolders
Q1 202410,294$33.0K<0.1%−1,700−14.2%ReducedHolders
Q4 202311,994$58.8K<0.1%+539+4.7%AddedHolders
Q3 202311,455$62.4K<0.1%−740−6.1%ReducedHolders
Q2 202312,195$81.8K<0.1%+69+0.6%AddedHolders
Q1 202312,126$107.1K<0.1%+12,126NewHolders
Q4 20220$00.0%−12,317−100.0%Sold outHolders
Q3 202212,317$88.0K<0.1%+11,162+966.4%AddedHolders
Q2 20221,155$9.00K<0.1%−373−24.4%ReducedHolders
Q1 20221,528$21.0K<0.1%+758+98.4%AddedHolders
Q4 2021770$22.0K<0.1%+180+30.5%AddedHolders
Q3 2021590$20.0K<0.1%00.0%UnchangedHolders
Q2 2021590$24.0K<0.1%−870−59.6%ReducedHolders
Q1 20211,460$59.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.